# Humira (adalimumab)

[Link to Decision Pathway](https://mygainwell-my.sharepoint.com/:w:/g/personal/cassandra_roach_gainwelltechnologies_com/EQ2p3kgBz1dKtw1LKBLnusoBAP6zPrrmVBBo2BCvyypI-w?e=DWQRkL)

[Recording for Decision Pathway](https://mygainwell-my.sharepoint.com/:v:/g/personal/cassandra_roach_gainwelltechnologies_com/EfEPqeszYrRMiSGf154f9DcB1HpcpmpdKwmN3Qci9z8e2g?e=L0OmMX&nav=eyJyZWZlcnJhbEluZm8iOnsicmVmZXJyYWxBcHAiOiJTdHJlYW1XZWJBcHAiLCJyZWZlcnJhbFZpZXciOiJTaGFyZURpYWxvZyIsInJlZmVycmFsQXBwUGxhdGZvcm0iOiJXZWIiLCJyZWZlcnJhbE1vZGUiOiJ2aWV3In19)

## Decision Pathway

Adalimumab: Humira </br>
*See bottom of this document for lists of steroids and potency </br>
==**All Humira approvals must be made at the HICL level**==

<table>
    <tr>
        <th>Question ID</th>
        <th>Question Text</th>
        <th>Choice Text</th>
        <th>Next Question ID</th>
    </tr>
</table>

## 0998

<table>
    <tr>
        <td rowspan="2"> 0998 </td>
        <td rowspan="2"> Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?</td>
        <td> New Start (initial authorization request) </td>
        <td> 0999 </td>
    </tr>
    <tr>
        <td> Continuation (re-authorization request) </td>
        <td> 1234 </td>
    </tr>
</table>

## 0999

<table>
    <tr>
        <td rowspan="2"> 0999 </td>
        <td rowspan="2"> Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling? See FDA labeling:
            <table> 
                <tr>
                    <td> Humira </td>
                    <td> 
                        <li> Rheumatoid Arthritis (moderate to severe, 18+ YO) </li>
                        <li> Juvenile Idiopathic Arthritis (moderate to severe, 2+ YO) </li>
                        <li> Psoriatic Arthritis (18+ YO) </li>
                        <li> Ankylosing Spondylitis </li>
                        <li> Crohn's Disease (6+ YO) </li>
                        <li> Ulcerative Colitis (moderate to severe, 5+ YO, Not to be used if patient tried TNF blockers) </li>
                        <li> Plaque Psoriasis (moderate to severe, 18+ YO) </li>
                        <li> Hidradenitis Suppurativa (moderate to severe, 12+ YO) </li>
                        <li> Uveitis (2+ YO) </li>
                    </td>
                </tr>
            </table>
        </td>
        <td> Y </td>
        <td> 1000 </td>
    </tr>
    <tr>
        <td> N </td>
        <td> Send to <u><b>MEDREVIEW</u></b> for a pharmacist to review/deny with language citing all criteria that is not met. </td>
    </tr>
</table>

## 1000

<table>
    <tr>
        <td rowspan="2">1000 </td>
        <td rowspan="2">Has the patient had an inadequate clinical response of at least <b><u>90 days</u> with at least <u>two applicable</u> first-line drugs</b> indicated for diagnosis? See first line treatments:
            <table>
                <tr>
                    <td>Rheumatoid Arthritis</td>
                    <td>Methotrexate (+/- glucocorticoids ex. prednisone, methylprednisolone, dexamethasone)</br>Hydroxychloroquine</br>Sulfasalazine</br>Leflunomide </td>
                </tr>
                <tr>
                    <td>Juvenile Idiopathic Arthritis</td>
                    <td>
                        <table>
                            <tr>
                                <td>Nonsteroidal antiinflammatory drugs</td>
                                <td>Any at therapeutic dosing (ibuprofen, naproxen, tolmetin, indomethacin, meloxicam, nabumetone, diclofenac, piroxicam, etodolac, celecoxib)</td>
                            </tr>
                            <tr>
                                <td>Conventional synthetic disease modifying antirheumatic drugs</td>
                                <td>Methotrexate, sulfasalazine, hydroxychloroquine, leflunomide, calcineurin inhibitors (cyclosporin A, tacrolimus)</td>
                            </tr>
                            <tr>
                                <td>Biologic disease-modifying antirheumatic drugs</td>
                                <td>Tumor necrosis factor inhibitors (adalimumab, etanercept, infliximab, golimumab, certolizumab pegol); other biologic response modifiers (abatacept, tocilizumab, anakinra, canakinumab)</td>
                            </tr>
                            <tr>
                                <td>Glucocorticoids</td>
                                <td>Oral (any); intravenous (any); intraarticular (triamcinolone acetonide, triamcinolone hexacetonide)</td>
                            </tr>
                        </table>
                    </td>
                </tr>
                <tr>
                    <td>Ankylosing Spondylitis</td>
                    <td>NSAIDS (ibuprofen, naproxen, meloxicam, celecoxib, diclofenac)</br>Sulfasalazine</br>Methotrexate</br>Xeljanz</td>
                </tr>
                <tr>
                    <td>Crohn's Disease</td>
                    <td>Azathioprine</br>Methotrexate</br>Budesonide</br>Prednisone</td>
                </tr>
                <tr>
                    <td>Ulcerative Colitis</td>
                    <td>Sulfasalazine</br>Methotrexazte</br>Budesonide</br>Prednisone</td>
                </tr>
                <tr>
                    <td>Plaque Psoriasis</td>
                    <td>*Must have documentation of inadequate clincial response to at least 90 days of phototherapy in addition to inadequate clinical response to at least two of the drugs below: </br>
                        <ul>
                            <li>Topical corticosteroid</li>
                            <li>Topical vitamin D analog</li>
                                <ul>
                                    <li>Calcipotriene</li>
                                    <li>Calcitriol ointment</li>
                                </ul>
                            <li>Topical retinoid</li>
                                <ul>
                                    <li>Azarotene (<i>Tazorac</i>) gel and cream</li>
                                </ul>
                            <li>Topical calcineurin inhibitor</li>
                                <ul>
                                    <li>Protopic (Tacrolimus ointment)</li>
                                    <li>Elidel (Primecrolimus cream)</li>
                                </ul>
                            <li>Topical coal tar</li>
                            <li>Methotrexate</li>
                            <li>Acitretin</li>
                            <li>Otezla</li>
                        </ul>
                    </td>
                </tr>
                <tr>
                    <td>Hidradenitis Suppurativa</td>
                    <td>
                        <ul>
                            <li>Clindamycin 1% topical solution</li>
                            <li>Clindamycin</li>
                            <li>Cyclosporine</li>
                            <li>Dapsone</li>
                            <li>Doxycycline</li>
                            <li>Ertapenem</li>
                            <li>Hormonal Agents for Females</li>
                                <ul>
                                    <li>Oral contraceptives</li>
                                    <li>Spironolactone</li>
                                </ul>
                            <li>Moxifoxacin</li>
                            <li>Oral retinoid</li>
                                <ul>
                                    <li>Acitretin</li>
                                    <li>Isotretinoin</li>
                                    <li>Amnesteem</li>
                                    <li>Claravis</li>
                                    <li>Myorisan</li>
                                    <li>Zenatane</li>
                                    <li>Absorica</li>
                                </ul>
                        </ul>
                    </td>
                </tr>
                <tr>
                    <td>Uveitis</td>
                    <td>
                        <ul>
                            <li>Azathioprine</li>
                            <li>Chlorambucil</li>
                            <li>Cyclosporine</li>
                            <li>Cyclophosphamide</li>
                            <li>Methotrexate</li>
                            </li>Mycophenolate</li>
                            <li>Oral Steroids</li>
                                <ul>
                                    <li>Dexamethasone</li>
                                    <li>Hydrocortisone</li>
                                    <li>Methylprednisolone</li>
                                    <li>Prednisone</li>
                                </ul>
                            <li>Tacrolimus</li>
                            <li>Steroid eye drops</li>
                        </ul>
                        <table>
                            <tr>
                                <th>Drug</th>
                                <th>Generic Name</th>
                            </tr>
                            <tr>
                                <td>Durezol (Pro)</td>
                                <td>difluprednate</td>
                            </tr>
                            <tr>
                                <td>Lotemax (Pro)</td>
                                <td>loteprednol</td>
                            </tr>
                            <tr>
                                <td>Ozurdex (Pro)</td>
                                <td>dexamethasone</td>
                            </tr>
                            <tr>
                                <td>Retisert (Pro)</td>
                                <td>fluocinolone</td>
                            </tr>
                            <tr>
                                <td>Eysuvis (Pro)</td>
                                <td>loteprednol</td>
                            </tr>
                            <tr>
                                <td>Maxidex (Pro)</td>
                                <td>dexamethasone</td>
                            </tr>
                            <tr>
                                <td>Lotemax SM</td>
                                <td>loteprednol</td>
                            </tr>
                            <tr>
                                <td>Flarex (Pro)</td>
                                <td>fluorometholone</td>
                            </tr>
                            <tr>
                                <td>Alrex (Pro)</td>
                                <td>loteprednol</td>
                            </tr>
                            <tr>
                                <td>Yutiq (Pro)</td>
                                <td>fluocinolone</td>
                            </tr>
                            <tr>
                                <td>Inveltys (Pro)</td>
                                <td>loteprednol</td>
                            </tr>
                            <tr>
                                <td>FML Forte Liquifilm (Pro)</td>
                                <td>fluorometholone</td>
                            </tr>
                            <tr>
                                <td>Triesence (Pro)</td>
                                <td> triamcinolone </td>
                            </tr>
                            <tr>
                                <td>Ocu-Dex</td>
                                <td>dexamethason</td>
                            </tr>
                            <tr>
                                <td>Iluvien (Pro)</td>
                                <td>fluorometholone</td>
                            </tr>
                            <tr>
                                <td>Xipere (Pro)</td>
                                <td>triamcinolone</td>
                            </tr>
                            <tr>
                                <td>Vexol</td>
                                <td>rimexolone</td>
                            </tr>
                            <tr>
                                <td>Trivaris (Pro)</td>
                                <td>triamcinolone</td>
                            </tr>
                            <tr>
                                <td>Prednisol</td>
                                <td>prednisolone</td>
                            </tr>
                            <tr>
                                <td>Pred Mild (Pro)</td>
                                <td>prednisolone</td>
                            </tr>
                            <tr>
                                <td>Pred Forte (Pro)</td>
                                <td>prednisolone</td>
                            </tr>
                            <tr>
                                <td>Omnipred</td>
                                <td>prednisolone</td>
                            </tr>
                            <tr>
                                <td>Ocu-Pred-A</td>
                                <td>prednisolone</td>
                            </tr>
                            <tr>
                                <td>Ocu-Pred</td>
                                <td>prednisolone</td>
                            </tr>
                            <tr>
                                <td>Inflamase Forte</td>
                                <td>prednisolone</td>
                            </tr>
                            <tr>
                                <td>FML Liquifilm</td>
                                <td>fluorometholone</td>
                            </tr>
                            <tr>
                                <td>FML (Pro)</td>
                                <td>fluorometholone</td>
                            </tr>
                            <tr>
                                <td>Fluor-Op</td>
                                <td>fluorometholone</td>
                            </tr>
                            <tr>
                                <td>Econopred Plus</td>
                                <td>prednisolone</td>
                            </tr>
                            <tr>
                                <td>Dexycu</td>
                                <td>dexamethasone</td>
                            </tr>
                            <tr>
                                <td>Dextenza (Pro)</td>
                                <td>dexanethasone</td>
                            </tr>
                            <tr>
                                <td>AK-Pred</td>
                                <td>prednisolone</td>
                            </tr>
                        </table>
            </table>
            This must be supported by claims in VUE360 or medical records (which must include medication/strength/dates).
        </td>
        <td>Y</td>
        <td>1002</td>
    </tr>
    <tr>
        <td>N</td>
        <td>Send to <u><b>MEDREVIEW</u></b> for a pharmacist to review/deny with language citing all criteria that is not met.</td>
    </tr>
</table>

### 1002

<table>
    <tr>
        <td rowspan="2">1002</td>
        <td rowspan="2">Does the patient have a current, active infection? Must be noted in the submitted documentation.</td>
        <td>Y</td>
        <td>Send to <u><b>MEDREVIEW</u></b> for a pharmacist to review/deny with language citing all criteria that is not met.</td>
    </tr>
    <tr>
        <td>N</td>
        <td>1004</td>
    </tr>
</table>

### 1004

<table>
    <tr>
        <td rowspan="2">1004</td>
        <td rowspan="2">Has the provider submitted documentation of a negative tuberculosis (TB) test prior to initiation of biologic therapy?</td>
        <td>Y</td>
        <td>1005</td>
    </tr>
    <tr>
        <td>N</td>
        <td>Send to <u><b>MEDREVIEW</u></b> for a pharmacist to review/deny with language citing all criteria that is not met.</td>
    </tr>
</table>

### 1005

<table>
    <tr>
        <td rowspan="3">1005</td>
        <td rowspan="3">What is the patient's diagnosis?</td>
        <td>Plaque psoriasis</td>
        <td>6000</td>
    </tr>
    <tr>
        <td>Ulcerative colitis</td>
        <td>7000</td>
    </tr>
    <tr>
        <td>Other</td>
        <td>Approve x 90 days at the highest dose requested (maintenance, not loading)</td>
    </tr>
</table>

### 6000

<table>
    <tr>
        <td rowspan="2">6000</td>
        <td rowspan="2">Has the patient had an inadequate clinical response to at least <u>90 days</u> of phototherapy?</td>
        <td>Y</td>
        <td>Approve x 90 days at the highest dose requested (maintenance, not loading).</td>
    </tr>
    <tr>
        <td>N</td>
        <td>Send to <u><b>MEDREVIEW</u></b> for a pharmacist to review/deny with language citing all criteria that is not met</td> 
    </tr>
</table>

### 7000

<table>
    <tr>
        <td rowspan="2">Has the patient had an inadequate clinical response after 90 days with one TNF inhibitor?</td>
        <td rowspan="2">Has the patient had an inadequate clinical response after 90 days with one TNF inhibitor? </br>
        TNF Inhibitors:
        <ul>
            <li>Remicade (infliximab)</li>
            <li>Enbrel (etanercept)</li>
            <li>Humira (adalimumab)</li>
            <li>Cimzia (certolizumab pegol)</li>
            <li>Simponi (golimumab)</li>
        </ul>
        </td>
        <td>Y</td>
        <td>Send to <u><b>MEDREVIEW</u></b> for a pharmacist to review/deny with language citing all criteria that is not met.</td>
    </tr>
    <tr>
        <td>N</td>
        <td>Approve x 90 days at the highest dose requested (maintenance, not loading).</td>
    </tr>
</table>

### 1234

<table>
    <tr>
        <td rowspan="2">1234</td>
        <td rowspan="2">
        <ol>
            <li>Confirm this is a reauthorization and an already approved PA with an authorization number (NOT an iPA) is on file.</li>
            <li>Confirm the provider submitted documentation of the patient's clinical response to treatment and ongoing safety monitoring.</li>
        </ol>
        </td>
        <td>Y</td>
        <td><u>Approve x 365 days.</u></td>
    </tr>
    <tr>
        <td>N</td>
        <td>Send to <u><b>MEDREVIEW</u></b> to deny with verbiage: <i>For a reauthorization, documentation of clinical response to treatment and ongoing safety monitoring is required.</i></td>
    </tr>
</table>

## Steroids and Potency

| High Potency b,f-h(steroids typically classified as II) |                                                                                                   |                                                                                          |
|:--------------------------------------------------------|:--------------------------------------------------------------------------------------------------|:-----------------------------------------------------------------------------------------|
| Amcinonide <ul><li>generics available</li></ul>         | Augmented* betamethasone dipropionate <ul><li>(Diprolene AF)</li><li>generics available</li></ul> | Betamethasone dipropionate <ul><li>(Diprolene)</li><li>generics available</li></ul>      |
| Clobetasol propionate <ul><li>(Impoyz)</ul></li>        | Desoximetasone <ul><li>(Topicort)</li><li>generics available</li></ul>                            | Diflorasone diacetate <ul><li>(ApexiCon E, Psorcon)</li><li>generics available</li></ul> |
| Fluocinonide <ul><li>generics available</li>            | Halcinonide <ul><li>(Halog)</li><li>generics available (cream)</li></ul>                          | Halobetasol propionate <ul><li>(Bryhali)</ul></li>                                       |
| Mometasone furoate <ul><li>generics available</ul></li> | Triamcinolone acetonide <ul><li>(Triderm)</li><li>generics available</li>                         |                                                                                          |

| Medium potency b,f,h-j (steroids typically classified as III, IV, or V)                               |                                                                                                  |                                                                                                 |
|:------------------------------------------------------------------------------------------------------|:-------------------------------------------------------------------------------------------------|:------------------------------------------------------------------------------------------------|
| Betamethasone dipropionate <ul><li>(Del-Beta, Betanate, Sernivo)</li><li>generics available</li></ul> | Betamethasone valerate <ul><li>(Beta Derm, Luxiq)</li><li>generics available</li></ul>           | Clocortolone pivalate <ul><li>(Cloderm)</li><li>generics available</li></ul>                    |
| Desoximetasone <ul><li>(Topicort)</li>generics available</li></ul>                                    | Fluocinolone acetonide<ul><li>Synalar</li><li>generics available</li></ul>                       | Fluocinonide (emulsified base) <ul><li>generics available</li></ul>                             |
| Flurandrenolide <ul><li>(Cordran, Nolix)</li><li>generics available</li></ul>                         | Fluticasone propionate <ul><li>(Cutivate)</li><li>generics available</li></ul>                   | Hydrocortisone butyrate <ul><li>(Locoid, Locoid Lipocream)</li><li>generics available</li></ul> |
| Hydrocortisone probutate <ul><li>(Pandel)</li></ul>                                                   | Hydrocortisone valerate <ul><li>(Westcart)</li><li>generics available</li></ul>                  | Mometasone furoate <ul><li>generics available</li></ul>                                         |
| Prednicarbate <ul><li>(Dermatop)</li><li>generics available</li></ul>                                 | Triamcinolone acetonide <ul><li>(Kenalog, Oralone, Triderm)</li><li>generics available</li></ul> | Augmented triamcinolone acetonide                                                               |

| Low potency b,f,h,j-l (steroids typically classified as VI or VII)                 |                                                                                                                            |                                                                                                                          |
|:-----------------------------------------------------------------------------------|:---------------------------------------------------------------------------------------------------------------------------|:-------------------------------------------------------------------------------------------------------------------------|
| Alclometasone dipropionate <ul><li>(Aclovate)</li><li>generics available</li></ul> | Desonide <ul><li>(Desonate, DesOwen, LoKara, Verdeso)</li><li>generics available</li></ul>                                 | Fluocinolone acetonide <ul><li>(Capex, Derma-Smoothe/FS, DermOtic, Flac Otic Oil)</li><li>generics available</li></ul>   |
| Hydrocortisone OTC <ul><li>generics available</li></ul>                            | Hydrocortisone <ul><li>(Cortaid, Cortizone-10)</li><li>Some 1% products available OTC</li><li>generics available</li></ul> | Hydrocortisone acetate <ul><li>(NuCort, NuZon)</li><li>1% ointment is available OTC</li><li>generics available</li></ul> |

## References

- [American College of Rheumatology 2021 Rheumatoid Arthritis Guidelines](https://assets.contentstack.io/v3/assets/bltee37abb6b278ab2c/blt9e44ccb701e1918c/63360f6775c0be225b8d943a/ra-guideline-2021.pdf){ :target="_blank" rel="noopener" }
- [American College of Rheumatology 2021 Juvenile Idiopathic Arthritis Guidelines](https://assets.contentstack.io/v3/assets/bltee37abb6b278ab2c/bltaf354c2958ca6774/jia-guideline-2021.pdf){ :target="_blank" rel="noopener" }
- [American College of Rheumatology 2018 Psoriatic Arthritis Guidelines](https://assets.contentstack.io/v3/assets/bltee37abb6b278ab2c/blt62e279f29f7d5435/6332144ffef925355ad7b25a/psoriatic-arthritis-guideline-2018.pdf){ :target="_blank" rel="noopener" }
- [American College of Rheumatology 2019 Axial Spondylarthritis Guidelines](https://rheumatology.org/axial-spondyloarthritis-guideline){ :target="_blank" rel="noopener" }
- [American Journal of Gastroenterology Crohn's Guidelines 2018](https://journals.lww.com/ajg/fulltext/2018/04000/acg_clinical_guideline__management_of_crohn_s.10.aspx){ :target="_blank" rel="noopener" }
- [American Gastroenterological Association 2020 UC guidelines](https://www.gastrojournal.org/article/S0016-5085(20)30018-4/fulltext){ :target="_blank" rel="noopener" }
- [Current Approach in the Diagnosis and Management of Panuveitis](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841373/){ :target="_blank" rel="noopener" }
- [North American Clinical Management Guidelines for Hidradenitis Suppurativa](https://www.jaad.org/article/S0190-9622(19)30367-6/pdf){ :target="_blank" rel="noopener" }
- [Joint AAD-NPF Guidelines of Care for the Management and Treatment of Psoriasis with Topical Therapy and Alternative Medicine Modalities for Psoriasis Severity Measures](https://pubmed.ncbi.nlm.nih.gov/32738429/){ :target="_blank" rel="noopener" }